Elizabeth Andrews, PhD, Vice President of Pharmacoepidemiology and Risk Management has been elected to the board of directors
International Society for Pharmacoepidemiology (ISPE). She will take office in August during the ICPE 25th Anniversary 2009 meeting in Providence, Rhode Island.
“All of us at RTI-HS were thrilled to hear the news about Elizabeth and wish her the best. - her expertise and talents are well deserving of this role and further substantiates RTI-HS’s scientific stature”, said Susana Perez-Gutthann, VP and Global Head of Epidemiology.
Dr. Andrews is a world-recognized epidemiologist with extensive experience in the pharmaceutical industry. She provides consultation for pharmaceutical companies and the US Food and Drug Administration on therapeutic risk management, and she directs research programs that evaluate drug safety and compliance with prescribing and treatment guidelines.
Previously, Dr. Andrews was Vice President, Worldwide Epidemiology, at a large pharmaceutical company.
She is a Fellow and Past President of the ISPE, a member of the editorial board of the Journal of Pharmacoepidemiology and Drug Safety, and co-editor of Pharmacovigilance. She is an Adjunct Associate Professor of the University of North Carolina School of Public Health and School of Pharmacy.
ISPE is an international organization dedicated to advancing the health of the public by providing a forum for the open exchange of scientific information and for the development of policy; education; and advocacy for the field of pharmacoepidemiology, including pharmacovigilance, drug utilization research, and therapeutic risk management. Their members represent the various scientific disciplines involved in studying drugs. Members are employed by the pharmaceutical industry, academic institutions, government agencies, non-profit and for-profit private organizations.
See http://www.pharmacoepi.org/ for more information.